While the CTLA-4 pathway appears to regulate anti-tumor immunity in the draining lymph nodes, the PD-1/PD-L1 axis appear to take place in the local tumor microenvironment (33–35), PD-1 is expressed highly on T cells following repeated activation and chronic stimulation (36). This evidence concerns the gene CD274 and neoplasm.